People: Genomic Health Inc (GHDX.OQ)
22 Apr 2019
Mr. Julian C. Baker serves as Lead Independent Director of the Company, effective March 1, 2012. Mr. Baker’s firm manages long-term investment funds, focused on publicly traded life sciences companies, for major university endowments and foundations. Mr. Baker’s career as a fund-manager began in 1994 when he and his brother co-founded a biotechnology investing partnership with the Tisch Family. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. Mr. Baker is also a director of Acadia Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc. and Incyte Corporation, where he serves as lead independent director. Mr. Baker holds an A.B. in Social Studies from Harvard University.
|Total Annual Compensation, USD||5,000|
|Restricted Stock Awards, USD||40,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||132,727|
|Fiscal Year Total, USD||177,727|